Cision PR Newswire

Malaysian Businesses Prioritise Sustainable Growth and Domestic Opportunities, ASEAN Survey Finds

Reeracoen Group x Rakuten Insight survey finds Malaysian businesses taking a measured approach to hiring and investment, with the strongest domestic-market focus among six ASEAN markets surveyed KUALA LUMPUR, Malaysia, Sept. 24, 2026 /PRNewswire/ -- Malaysian businesses are responding to cost and inflation pressures with operational discipline and...

HashKey Exchange Achieves SOC 1 Type 2 and SOC 2 Type 2 Certifications

HONG KONG, May 11, 2025 /PRNewswire/ -- HashKey Exchange, the largest* licensed virtual asset exchange in Hong Kong, today announced that HashKey Custody Services...

Lecomely Launches AirEdge A3 Multi-styler: Uniquify Your Style with All-in-One Hair Mastery

SHENZHEN, China, May 11, 2025 /PRNewswire/ -- Lecomely, a pioneering beauty brand, revolutionizes personal care with its science-driven innovations, proudly introducing the Lecomely AirEdge A3 Multi-styler...

AWDPI Honored at the United Nations: Empowering Asian Women, Advancing Global Gender Equality

From Paris to New York, AWDPI's mission to empower Asian women earns global recognition and catalyzes new action at CSW69. NEW YORK, May...

Abu Dhabi and Japan sign agreements to strengthen partnerships, boost bilateral trade and investments

ABU DHABI, UAE, May 11, 2025 /PRNewswire/ -- An Abu Dhabi economic delegation, led by the Abu Dhabi Department of Economic Development (ADDED), concluded a...

TCL CSOT to Unveil Industry-Leading Display Innovations at SID Display Week 2025

SAN JOSE, Calif., May 11, 2025 /PRNewswire/ -- TCL CSOT, a global leader in display technologies, is set to participate in SID Display Week...

Skyline Therapeutics Presents Late-Breaking Abstract on SKG1108, a Novel Optogenetic Gene Therapy for Retinitis Pigmentosa, at ASGCT 2025

SHANGHAI, May 11, 2025 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven clinical-stage gene therapy company focused on developing unique and novel solutions for rare and...